Literature DB >> 21577212

Absence of Thy-1 results in TGF-β induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts.

Gustavo Ramírez1, James S Hagood, Yan Sanders, Remedios Ramírez, Carina Becerril, Lourdes Segura, Lourdes Barrera, Moisés Selman, Annie Pardo.   

Abstract

Fibroblasts differ in a variety of phenotypic features, including the expression of Thy-1 a glycophosphatidylinositol-linked glycoprotein. Fibroblasts in idiopathic pulmonary fibrosis (IPF) are Thy-1 negative, whereas most fibroblasts from normal lungs are Thy-1 positive. However, the functional consequences of the absence of Thy-1 are not fully understood. We analyzed the expression of Thy-1 in several primary fibroblasts lines derived from IPF, hypersensitivity pneumonitis (HP), and normal human lungs. We found that a high proportion, independently of their origin, expressed Thy-1 in vitro. We identified a primary culture of HP fibroblasts, which did not express Thy-1, and compared several functional activities between Thy-1 (-) and Thy-1 (+) fibroblasts. Thy-1 (-) fibroblasts were smaller (length: 41.3±20.8 μ versus 83.1±40 μ), showed increased proliferative capacity and enhanced PDGF-induced transmigration through collagen I (59.9% versus 42.2% over control under basal conditions, P<0.01). Likewise, Thy-1 (-) fibroblasts either spontaneously or after TGF-β stimulation demonstrated stronger contraction of collagen matrices (eg, 0.17±0.03 versus 0.6±0.05 cm² after TGF-β stimulation at 24 h; P<0.01). Thy-1 (-) lung fibroblasts stimulated with TGF-β1 expressed MMP-9, an enzyme that is usually not produced by lung fibroblasts. TGFβ-induced MMP-9 expression was reversible upon re-expression of Thy-1 after transfection with full-length Thy-1. β-glycan, a TGF-β receptor antagonist abolished MMP-9 expression. TGF-β1-induced MMP-9 in Thy-1 (-) fibroblasts depended on the activation of ERK1/2 signaling pathway. Finally, we demonstrated that fibroblasts from IPF fibroblastic foci, which do not express Thy-1 exhibit strong staining for immunoreactive MMP-9 protein in vivo. These findings indicate that loss of Thy-1 in human lung fibroblasts induces a fibrogenic phenotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21577212      PMCID: PMC5683845          DOI: 10.1038/labinvest.2011.80

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  31 in total

1.  TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?

Authors:  M Selman; V Ruiz; S Cabrera; L Segura; R Ramírez; R Barrios; A Pardo
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-09       Impact factor: 5.464

2.  Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.

Authors:  R Gum; H Wang; E Lengyel; J Juarez; D Boyd
Journal:  Oncogene       Date:  1997-03-27       Impact factor: 9.867

3.  Biology of fibroblasts and myofibroblasts.

Authors:  Sem H Phan
Journal:  Proc Am Thorac Soc       Date:  2008-04-15

Review 4.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

Review 5.  Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

Authors:  M Selman; T E King; A Pardo
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

6.  Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion.

Authors:  X N Meng; Y Jin; Y Yu; J Bai; G Y Liu; J Zhu; Y Z Zhao; Z Wang; F Chen; K-Y Lee; S B Fu
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

7.  Thy-1 regulates fibroblast focal adhesions, cytoskeletal organization and migration through modulation of p190 RhoGAP and Rho GTPase activity.

Authors:  Thomas H Barker; Hernan E Grenett; Mark W MacEwen; Samuel G Tilden; Gerald M Fuller; Jeffrey Settleman; Anne Woods; Joanne Murphy-Ullrich; James S Hagood
Journal:  Exp Cell Res       Date:  2004-05-01       Impact factor: 3.905

8.  Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway.

Authors:  Ya-Chung Tian; Yung-Chang Chen; Chiz-Tzung Chang; Cheng-Chieh Hung; Mai-Szu Wu; Aled Phillips; Chih-Wei Yang
Journal:  Exp Cell Res       Date:  2007-03-30       Impact factor: 3.905

9.  Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.

Authors:  Annie Pardo; Kevin Gibson; José Cisneros; Thomas J Richards; Yinke Yang; Carina Becerril; Samueal Yousem; Iliana Herrera; Victor Ruiz; Moisés Selman; Naftali Kaminski
Journal:  PLoS Med       Date:  2005-09-06       Impact factor: 11.069

10.  Fibrotic myofibroblasts manifest genome-wide derangements of translational control.

Authors:  Ola Larsson; Deanna Diebold; Danhua Fan; Mark Peterson; Richard Seonghun Nho; Peter B Bitterman; Craig A Henke
Journal:  PLoS One       Date:  2008-09-16       Impact factor: 3.240

View more
  36 in total

1.  Controlling the Balance of Fibroblast Proliferation and Differentiation: Impact of Thy-1.

Authors:  Manuela Schmidt; Danny Gutknecht; Jan C Simon; Jan-Niklas Schulz; Beate Eckes; Ulf Anderegg; Anja Saalbach
Journal:  J Invest Dermatol       Date:  2015-03-04       Impact factor: 8.551

2.  Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Qiyuan Zhou; Tianji Chen; Wei Zhang; Melike Bozkanat; Yongchao Li; Lei Xiao; Richard B van Breemen; John W Christman; Jacob I Sznajder; Guofei Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

Review 3.  Molecular biomarkers in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Kevin K Brown; Harold R Collard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-26       Impact factor: 5.464

Review 4.  Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis.

Authors:  David N O'Dwyer; Shanna L Ashley; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

Review 5.  The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.

Authors:  Daniel Karin; Yukinori Koyama; David Brenner; Tatiana Kisseleva
Journal:  Differentiation       Date:  2016-08-31       Impact factor: 3.880

6.  Alcohol-Induced Interleukin-17 Expression Causes Murine Lung Fibroblast-to-Myofibroblast Transdifferentiation via Thy-1 Down-Regulation.

Authors:  Wendy A Neveu; Bashar S Staitieh; Stephen T Mills; David M Guidot; Viranuj Sueblinvong
Journal:  Alcohol Clin Exp Res       Date:  2019-06-03       Impact factor: 3.455

7.  Development of antisense oligonucleotide (ASO) technology against Tgf-β signaling to prevent scarring during flexor tendon repair.

Authors:  Alayna E Loiselle; Kiminori Yukata; Michael B Geary; Sirish Kondabolu; Shanshan Shi; Jennifer H Jonason; Hani A Awad; Regis J O'Keefe
Journal:  J Orthop Res       Date:  2015-06       Impact factor: 3.494

Review 8.  Personalized medicine: applying 'omics' to lung fibrosis.

Authors:  Jose D Herazo-Maya; Naftali Kaminski
Journal:  Biomark Med       Date:  2012-08       Impact factor: 2.851

9.  Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis.

Authors:  Yukinori Koyama; Ping Wang; Shuang Liang; Keiko Iwaisako; Xiao Liu; Jun Xu; Mingjun Zhang; Mengxi Sun; Min Cong; Daniel Karin; Kojiro Taura; Chris Benner; Sven Heinz; Tapan Bera; David A Brenner; Tatiana Kisseleva
Journal:  J Clin Invest       Date:  2017-03-13       Impact factor: 14.808

10.  TGF-β1 epigenetically modifies Thy-1 expression in primary lung fibroblasts.

Authors:  Wendy A Neveu; Stephen T Mills; Bashar S Staitieh; Viranuj Sueblinvong
Journal:  Am J Physiol Cell Physiol       Date:  2015-09-02       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.